Charles River (CRL) Q2 Earnings Beat Estimates, 2024 View Down

Charles River Laboratories International, Inc. (CRL) reported second-quarter 2024 adjusted earnings per share (EPS) of $2.80, which increased 4.1% year over year. The figure surpassed the Zacks Consensus Estimate by 17.2%. On a GAAP basis, earnings declined 7.9% year over year to$ 1.74 per share. Revenues Revenues totaled $1.03 billion, in line with the Zacks Consensus Estimate. However, the top line declined 2.8% from the year-ago quarter's level (down 3.2% organically, excluding the impact of acquisition, ...